XpresSpa Group Has Begun Construction of New XpresCheck™ COVID-19 Pop-Up Testing Facility at Denver International Airport
December 07 2020 - 8:30AM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced that it has begun
construction of an XpresCheck™ COVID-19 testing facility at Denver
International Airport that is expected to be fully operational by
mid-December.
XpresCheck is currently building a pop-up
facility in the now closed Brookstone location at Concourse B,
post-security. This facility will host six separate testing rooms
with an anticipated capacity to administer over 400 tests per day.
COVID-19 testing options will include the Rapid Molecular COVID-19
Test and the Polymerase Chain Reaction (PCR) Test.
Doug Satzman, XpresSpa CEO, stated, "As cases
continue to rise in Colorado and throughout the country, we are
pleased to launch XpresCheck at Denver International Airport, which
will be our first pop-up location and fifth COVID-19 testing
facility across the country. This new pop-up building methodology
will enable us to accelerate our rollout to additional airports at
a lower cost than our original modular constructed facilities at
JFK, Newark, and Logan airports. While our current focus is
providing convenient, reliable COVID-19 testing and related medical
services, our long-term goal is to become the leading provider in
the travel, health and wellness category by helping people manage
medical conditions as they pass through the largest U.S.
airports.”
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading
global health and wellness holding company. XpresSpa Group’s core
asset, XpresSpa, is a leading airport retailer of spa services and
related health and wellness products, with 50 locations in 25
airports globally. Through its XpresTest, Inc. subsidiary, the
Company also provides COVID-19 screening and testing, rapid testing
services for other communicable diseases that include influenza,
mononucleosis and group A streptococcus, and flu vaccination
services under its XpresCheck™ brand. Current XpresCheck Wellness
Centers include JFK International Airport, Newark Liberty
International Airport, Logan International Airport, and Phoenix Sky
Harbor International Airport. To learn more about XpresSpa Group,
visit: www.XpresSpaGroup.com. To learn more about XpresSpa, visit
www.XpresSpa.com. To learn more about XpresCheck, visit
www.XpresCheck.com.
About Denver International
Airport
Denver International Airport is the
fifth-busiest airport in the United States, with more than 69
million passengers traveling through the airport in 2019. DEN is
the primary economic engine for the state of Colorado, generating
more than $33 billion for the region annually. For more information
visit www.FlyDenver.com.
Forward-Looking Statements
This press release may contain "forward-looking"
statements within the meaning of Section 27A of the Securities Act
of 1933, and Section 21E of the Securities Exchange Act of 1934.
These include statements preceded by, followed by or that otherwise
include the words "believes," "expects," "anticipates,"
"estimates," "projects," "intends," "should," "seeks," "future,"
"continue," or the negative of such terms, or other comparable
terminology. In particular, these statements include, without
limitation, statements about our expectations relating to our new
XpresCheck™ concept, being able to expand testing to other
communicable diseases as well as administer vaccinations for the
seasonal flu, our positioning to be part of the national rollout of
a COVID-19 vaccination when it becomes available (including whether
such vaccination becomes available in the near term), the degree to
which our public testing model assists passengers meet testing
requirements in select states and countries, our ability to
identify and gain access to the latest and best COVID-19 testing
methodologies and equipment, and our ability further expand our
initial sites, and our overall ability to manage the regulatory
challenges associated with this business line.
Forward-looking statements relating to expectations about future
results or events are based upon information available to XpresSpa
Group as of today's date and are not guarantees of the future
performance of the company, and actual results may vary materially
from the results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Grossir@xpresspagroup.com(203) 682-8253
Media:Julie
FergusonJulie@jfprmedia.com(312) 385-0098
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2023 to Apr 2024